跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ENZALUDEZ SOFT CAPSULE 40MG - HSA Drug Approval Details
Approvals
/
HSA
/
ENZALUDEZ SOFT CAPSULE 40MG
Approved
THERAPEUTIC
ENZALUDEZ SOFT CAPSULE 40MG
Lotus Pharmaceutical Co. Ltd. (TAIWAN)
🇸🇬 Health Sciences Authority
Approval Date
Apr 8, 2026
Approval ID
02c566d18780e97d
Company
Lotus Pharmaceutical Co. Ltd. (TAIWAN)
Type
Therapeutic
Approval Details
Approval Id
02c566d18780e97d
Drug Name
ENZALUDEZ SOFT CAPSULE 40MG
Product Name
ENZALUDEZ SOFT CAPSULE 40MG
Approval Number
SIN17513P
Approval Date
2026-04-08
Registrant
SANDOZ SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE, LIQUID FILLED
Route Of Administration
ORAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 8, 2026
Approval ID
02c566d18780e97d
Type
Therapeutic
Back to HSA Approvals